🌟 Pharmidex is proud to sponsor CamMedChem’25! 🌟
September 12, 2025
We’re delighted to announce that
Pharmidex will be an official sponsor of
CamMedChem’25, the renowned meeting organized by the Royal Society of Chemistry’s Biomolecular Chemistry Special Interest Group
This year’s theme promises cutting-edge discussions in medicinal chemistry, biomolecular interactions and the latest trends in small molecule and chemical biology research.
We’re honoured to support such a pivotal forum for scientists, drug discovery experts and academic innovators to exchange ideas, foster collaborations, and advance therapeutic discovery.
👉 We look forward to:
Learning from the powerful scientific insights shared at the meeting
Exploring new partnerships that further the translation of biomolecular science into impactful therapies
We can’t wait to see you in Cambridge for CamMedChem’25!

#CamMedChem25 #MedicinalChemistry #DrugDiscovery #Pharmidex #BMCS

Science is serious… but Pancake Day is not. Yesterday we took a short pause from studies, data and reports to enjoy some well-earned pancakes together as a team. With Ramadan also beginning, we made sure there were plenty saved for colleagues breaking their fast later in the evening. At Pharmidex , we’re proud of the work we deliver, but we’re equally proud of the people behind it. Small moments like this remind us that strong teams are built not only in the lab, but around the table too. Thank you to everyone for your hard work and for making our culture what it is. 🙌

We’re proud to announce that Pharmidex has joined the Good Clinical Practice (GCP) Network , a global collaboration advancing ICH-GCP excellence in clinical research. For us, quality and data integrity are not box-ticking exercises, they are fundamental to credible science and responsible drug development. From pre-clinical research through to clinical delivery, we are committed to: • Regulatory rigour • Ethical conduct • Participant protection • Scientifically robust data Joining the GCP Network further strengthens that commitment. We look forward to contributing to a global community dedicated to raising the bar across clinical research.

Pharmidex now offers integrated in vivo CAR-T study support , combining robust in-life pharmacology with advanced f low cytometry –based cellular analysis. We support early-stage CAR-T and cell therapy programmes with translational data on efficacy, expansion, persistence and phenotype delivered through a single collaborative CRO partner. Let’s talk. 🌐 www.pharmidex.com




